Valuation West Pharmaceutical Services, Inc. Berne S.E.
Stocks
WPS
US9553061055
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Berne S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 281.30 CHF | -0.71% |
|
-1.79% | - |
| 08-03 | Is everything under control? | |
| 08-01 | Amgen discloses data breach involving patient health information | RE |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 24,591 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 24.23% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 24,087 | 23,552 | 23,132 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 25.42% | -2.22% | -1.78% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 40.7x | 35.4x | 31.6x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 7.85x | 6.85x | 6.06x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.5x | 2.4x | 2.6x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.29x | 6.86x | 6.38x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7.14x | 6.57x | 6x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 25.6x | 22.6x | 20x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 31.8x | 27.8x | 24.3x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 55.9x | 41.5x | 31.9x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.79% | 2.41% | 3.13% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.9025 | 0.9729 | 1.121 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.26% | 0.28% | 0.32% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.575 | 9.865 | 11.04 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.5% | 9.86% | 10.2% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,375 | 3,587 | 3,854 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 940.4 | 1,041 | 1,159 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 757.5 | 848.4 | 952.3 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 614.5 | 701.2 | 778 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -503.3 | -1,039 | -1,458 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 349.42 | 349.42 | 349.42 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,376 | - | - |
| Announcement Date | 2/17/22 A | 2/16/23 A | 2/15/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.91x | 4.3x | 16.65x | 2.31% | 193B | ||
| 20.68x | 3.58x | 12.58x | 3.26% | 117B | ||
| 17.18x | 0.2x | 12.43x | 0.76% | 59.89B | ||
| 32.51x | 8.12x | 20.71x | 1.22% | 56.01B | ||
| 35.34x | 3.41x | 11.7x | 2.14% | 49.96B | ||
| 35.98x | 6.33x | 19.87x | -.--% | 33.87B | ||
| 46.51x | 1.32x | 12.08x | 0.16% | 31.36B | ||
| 20.88x | 3.19x | 11.7x | 1.4% | 24.77B | ||
| 40.75x | 7.14x | 25.62x | 0.26% | 24.59B | ||
| Average | 31.30x | 4.18x | 15.93x | 1.28% | 65.53B | |
| Weighted average by Cap. | 29.45x | 4.06x | 15.49x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- WPS Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
















